222 related articles for article (PubMed ID: 8938656)
1. Opioid receptor-mediated control of acetylcholine release in human neocortex tissue.
Feuerstein TJ; Gleichauf O; Peckys D; Landwehrmeyer GB; Scheremet R; Jackisch R
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):586-92. PubMed ID: 8938656
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
3. delta 1-Opioid receptor-mediated control of acetylcholine (ACh) release in human neocortex slices.
Feuerstein TJ; Albrecht C; Wessler I; Zentner J; Jackisch R
Int J Dev Neurosci; 1998; 16(7-8):795-802. PubMed ID: 10198826
[TBL] [Abstract][Full Text] [Related]
4. Mu and kappa opioid receptor modulation of 5-HT3 and NK-3 receptor-evoked release of acetylcholine from the guinea-pig ileum myenteric plexus.
Fox AJ; Morton IK
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):8-15. PubMed ID: 1723152
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50, 488H in isolated human right atria strips.
Llobell F; Laorden ML
Neuropeptides; 1995 Aug; 29(2):115-9. PubMed ID: 7477762
[TBL] [Abstract][Full Text] [Related]
6. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F
Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928
[TBL] [Abstract][Full Text] [Related]
7. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
8. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation by muscimol and baclofen on antinociception induced by morphine, beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Kim YH; Choi YS; Yoo JS; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):614-9. PubMed ID: 9053732
[TBL] [Abstract][Full Text] [Related]
10. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
[TBL] [Abstract][Full Text] [Related]
12. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
13. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
14. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
Yuan CS
Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
[TBL] [Abstract][Full Text] [Related]
15. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase.
Heijna MH; Hogenboom F; Mulder AH; Schoffelmeer AN
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):627-32. PubMed ID: 1321956
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Devine DP; Leone P; Pocock D; Wise RA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
[TBL] [Abstract][Full Text] [Related]
18. Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices.
Arenas E; Alberch J; Sanchez Arroyos R; Marsal J
Brain Res; 1990 Jul; 523(1):51-6. PubMed ID: 1976420
[TBL] [Abstract][Full Text] [Related]
19. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
Yuan CS; Foss JF
Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
[TBL] [Abstract][Full Text] [Related]
20. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
Danzebrink RM; Green SA; Gebhart GF
Pain; 1995 Oct; 63(1):39-47. PubMed ID: 8577489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
